OSIRIS HEALTH LIMITEDActive

Company number 09506655Private limited companyIncorporated 2015

Key figures

£110,803+1.8%
Net assets 2023/24
+0.9%
Average annual growth 2019/20–2023/24
050 k100 k150 k200 k2019/202020/212021/222022/232023/24

Like most small UK companies, OSIRIS HEALTH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand————46,904
Total assets189,334175,712192,176128,515137,533
Total liabilities83,4948,29395,61925,13427,687
Net assets / total equity107,038164,199101,294108,805110,803
Average number of employees53333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: OSIRIS HEALTH LIMITED

Company

OSIRIS HEALTH LIMITED is a private limited company registered with Companies House under company number 09506655. It was incorporated on 24 Mar 2015. Its status is active. The registered office is in Chorley (PR7). Its nature of business (SIC 2007) is specialists medical practice activities (86220), other human health activities (86900).

Accounts

The latest accounts in the database are for 2023/24 (period ending 31 May 2024); the company files audit-exempt subsidiary. Net assets were £110,803, up 1.8% on the previous year. Cash at bank and in hand was £46,904. Total assets were £137,533 and total liabilities £27,687. The company had an average of 3 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 24 Mar 2027.